News &amp; Updates

GLP-1 RAs up risks of GERD, complication vs SGLT-2 inhibitors

Compared with using SGLT-2 inhibitors, treatment with GLP-1 receptor agonists (RAs) may increase the risk for gastroesophageal reflux disease (GERD) and its complications in patients with type 2 diabetes (T2D), a recent study has shown.

GLP-1 RAs up risks of GERD, complication vs SGLT-2 inhibitors

Behavioural noninferior to drug therapy for OAB symptoms in Parkinson’s disease

In the treatment of overactive bladder (OAB) in patients with Parkinson’s disease (PD), behavioural therapy compares favourably with drug therapy, according to the results of a noninferiority study.

Behavioural noninferior to drug therapy for OAB symptoms in Parkinson’s disease

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

COVID-19 appears to have adverse consequences for patients with cancer, including increased hospitalization, treatment disruption, and death, according to a study.

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

Once-daily roflumilast foam may bring relief in psoriasis

26 Jul 2025 by

Treatment with once-daily roflumilast foam appears to improve the signs and symptoms of psoriasis of the scalp and body, with low rates of adverse events, according to the results of the phase III ARRECTOR trial.

Once-daily roflumilast foam may bring relief in psoriasis

26 Jul 2025

BMI with WC threshold upgrades mortality prediction in postmenopausal women

Further stratification of BMI categories by waist circumference (WC) thresholds can improve prediction of mortality risk among postmenopausal women, suggests a recent study, noting the association of larger WC with greater mortality.

BMI with WC threshold upgrades mortality prediction in postmenopausal women

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

Maternal immunization with the bivalent respiratory syncytial virus (RSV) prefusion F vaccine (RSVpreF) helps lower the incidence of RSV-related lower respiratory tract disease (LRTD) and severe LRTD leading to hospitalization among infants from birth through age 6 months, according to real-world data from the BERNI study.

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

$ABI-009 safe in children with refractory epilepsy$

ABI-009 safe in children with refractory epilepsy

In the treatment of paediatric patients with medically and surgically refractory epilepsy, the use of ABI-009 appears safe and tolerable, with early signs of efficacy, according to data from a phase I study.

ABI-009 safe in children with refractory epilepsy

Meta-analysis points to exercise as effective treatment strategy for insomnia

25 Jul 2025 by

Exercise interventions such as yoga, Tai Chi, and walking or jogging help improve sleep outcomes for people with insomnia, according to the results of a meta-analysis.

Meta-analysis points to exercise as effective treatment strategy for insomnia

25 Jul 2025

BMI, CCI predict biologic response in psoriasis patients

Several factors, including BMI and Charlson Comorbidity Index (CCI), can help predict treatment response among patients with psoriasis, suggests a study.

BMI, CCI predict biologic response in psoriasis patients